Want to join the conversation?
$PX reported a rise in 2Q16 earnings driven by lower costs and expenses. Net income rose to $399MM or $1.39 per share from $308MM or $1.06 per share last year. Sales slid to $2.67Bil from $2.74Bil, primarily due to impact of negative currency translation and lower cost pass-through.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?